Non-metastatic
Showing 1 - 25 of >10,000
Darolutamide, Enzalutamide and Apalutamide and How Well These
Not yet recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Apalutamide
- +2 more
-
Whippany, New JerseyBayer
Aug 25, 2023
Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant
Not yet recruiting
- Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Liver Transplant
-
Newark, New Jersey
- +1 more
Nov 14, 2023
Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)
Not yet recruiting
- Breast Cancer
- +3 more
- Lipidomic analysis for breast cancer patients
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Sep 4, 2023
Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)
Recruiting
- Nasopharyngeal Carcinoma
- Intensity-Modulated Radiotherapy
- Reduction CTVp1
- Non-reduction CTVp1
-
Zhongshan, Guangdong, ChinaZhongshan City People's Hospital
Aug 8, 2023
Colorectal Cancer Trial (Pembrolizumab)
Recruiting
- Colorectal Cancer
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Jan 3, 2023
Called DEAR, to Learn More About Treatment With Darolutamide,
Active, not recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Whippany, New JerseyBayer
Jan 13, 2023
Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)
Not yet recruiting
- Hypopharyngeal Cancer
- Cisplatin/Nedaplatin, albumin paclitaxel
- (no location specified)
May 5, 2023
Empathy in Curative Treatment Outcomes of Non-metastatic
Not yet recruiting
- Non-metastatic Colorectal Cancer
- +4 more
- (no location specified)
Jul 6, 2022
Breast Cancer Trial (Face to face and telephonic interviews)
Not yet recruiting
- Breast Cancer
- Face to face and telephonic interviews
- (no location specified)
Sep 8, 2022
Retroperitoneal Sarcoma Trial in Washington, Baltimore (Hypofractionated Proton Beam Therapy)
Not yet recruiting
- Retroperitoneal Sarcoma
- Hypofractionated Proton Beam Therapy
-
Washington, District of Columbia
- +1 more
Jul 15, 2022
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +
Not yet recruiting
- Stage I Colon Cancer
- +2 more
- Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
- +2 more
-
Houston, TexasBaylor College of Medicine
May 22, 2023
Prognostic Immune Biomarkers in HNSCC
Completed
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Tumour immunoprofile evaluation
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Jul 3, 2023
Non-Metastatic Tumor Trial in Liège (Self-hypnosis/self-care)
Withdrawn
- Non-Metastatic Neoplasm
- Self-hypnosis/self-care
-
Liège, Belgium
- +1 more
Jul 4, 2023
NSCLC Trial in Chongqing (procedure, drug, radiation)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- bronchial artery interventional therapy
- +3 more
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
May 27, 2023
Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)
Not yet recruiting
- Hepatocellular Carcinoma
- TACE（transcatheter arterial chemoembolization）
- +2 more
- (no location specified)
Jun 5, 2023
Prostate Cancer Trial in Aurora, Fort Collins (Grape Seed Extract)
Recruiting
- Prostate Cancer
- Grape Seed Extract
-
Aurora, Colorado
- +1 more
Aug 22, 2022
Unresectable, Non-metastatic Hepatocellular Carcinoma Trial in China (biological, drug, procedure)
Recruiting
- Unresectable, Non-metastatic Hepatocellular Carcinoma
- AK104
- +2 more
-
Beijing, Beijing, China
- +4 more
Aug 11, 2022
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
The HELPP Score: A Pretreatment Score to Predict Survival in
Not yet recruiting
- Pancreatic Adenocarcinoma
-
Vienna, AustriaDepartment of General Surgery, Division of Visceral Surgery, Med
Feb 21, 2023
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena
Active, not recruiting
- Adenocarcinoma of the Prostate
- +5 more
- phenelzine sulfate
- +2 more
-
Beverly Hills, California
- +3 more
Aug 19, 2022
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Central Nervous System Metastatic EGFR Mutation Positive NSCLC
Not yet recruiting
- NSCLC
-
Changsha, Hunan, ChinaHunan Cancer hospital
Aug 6, 2023
